Winner Medical Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Winner Medical heeft een totaal eigen vermogen van CN¥12.1B en een totale schuld van CN¥2.2B, wat de schuld-eigenvermogensverhouding op 18.3% brengt. De totale activa en totale passiva bedragen respectievelijk CN¥17.8B en CN¥5.8B. De EBIT Winner Medical is CN¥424.2M waardoor de rentedekking -2.5 is. Het heeft contanten en kortetermijnbeleggingen van CN¥5.7B.

Belangrijke informatie

18.3%

Verhouding schuld/eigen vermogen

CN¥2.21b

Schuld

Rente dekkingsratio	-2.5x
Contant	CN¥5.71b
Aandelen	CN¥12.08b
Totaal verplichtingen	CN¥5.76b
Totaal activa	CN¥17.84b

Recente financiële gezondheidsupdates

Is Winner Medical (SZSE:300888) Using Too Much Debt?

Jul 15

Does Winner Medical (SZSE:300888) Have A Healthy Balance Sheet?

Mar 17

Recent updates

Winner Medical Co., Ltd.'s (SZSE:300888) Shares Lagging The Industry But So Is The Business

Sep 16

Estimating The Fair Value Of Winner Medical Co., Ltd. (SZSE:300888)

Aug 19

Investors Could Be Concerned With Winner Medical's (SZSE:300888) Returns On Capital

Aug 02

Is Winner Medical (SZSE:300888) Using Too Much Debt?

Jul 15

Winner Medical (SZSE:300888) Will Pay A Smaller Dividend Than Last Year

May 31

There May Be Reason For Hope In Winner Medical's (SZSE:300888) Disappointing Earnings

May 01

There Are Reasons To Feel Uneasy About Winner Medical's (SZSE:300888) Returns On Capital

Apr 26

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( CN¥9.5B ) 300888 } overtreffen de korte termijn passiva ( CN¥4.9B ).

Langlopende schulden: De kortetermijnactiva 300888 ( CN¥9.5B ) overtreffen de langetermijnschulden ( CN¥826.0M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 300888 heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van 300888 is de afgelopen 5 jaar gestegen van 8.9% naar 18.3%.

Schuldendekking: De schuld van 300888 wordt goed gedekt door de operationele kasstroom ( 60.2% ).

Rentedekking: 300888 verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.

Winner Medical Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Is Winner Medical (SZSE:300888) Using Too Much Debt?

Does Winner Medical (SZSE:300888) Have A Healthy Balance Sheet?

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.29 (vs CN¥2.49 in 3Q 2023)

Now 21% overvalued after recent price rise

Investor sentiment deteriorates as stock falls 22%

Winner Medical Co., Ltd. to Report Q3, 2024 Results on Oct 29, 2024

Investor sentiment improves as stock rises 19%

Consensus EPS estimates increase by 13%

Winner Medical Co., Ltd. (SZSE:300888) acquired 75.2% stake in Global Resources International, Inc. for $120 million.

Winner Medical Co., Ltd. Announces Interim Cash Dividend of the Year 2024 of A Shares, Payable on 30 September 2024

Winner Medical Co., Ltd. Approves Interim Dividend for the Year 2024

Winner Medical Co., Ltd.'s (SZSE:300888) Shares Lagging The Industry But So Is The Business

Consensus EPS estimates fall by 14%

Second quarter 2024 earnings released: EPS: CN¥0.35 (vs CN¥0.52 in 2Q 2023)

High number of new directors

Estimating The Fair Value Of Winner Medical Co., Ltd. (SZSE:300888)

Investors Could Be Concerned With Winner Medical's (SZSE:300888) Returns On Capital

Is Winner Medical (SZSE:300888) Using Too Much Debt?

Winner Medical Co., Ltd. to Report First Half, 2024 Results on Aug 20, 2024

Winner Medical (SZSE:300888) Will Pay A Smaller Dividend Than Last Year

Dividend of CN¥0.50 announced

Winner Medical Co., Ltd. Announces Final Cash Dividend on A Shares for 2023, Payable on 04 June 2024

Price target decreased by 11% to CN¥37.77

Consensus EPS estimates fall by 20%

There May Be Reason For Hope In Winner Medical's (SZSE:300888) Disappointing Earnings

Winner Medical Co., Ltd. Proposes Final Cash Dividend for the Year 2023

There Are Reasons To Feel Uneasy About Winner Medical's (SZSE:300888) Returns On Capital

First quarter 2024 earnings released: EPS: CN¥0.31 (vs CN¥0.64 in 1Q 2023)

Winner Medical Co., Ltd., Annual General Meeting, May 21, 2024

Estimating The Fair Value Of Winner Medical Co., Ltd. (SZSE:300888)

Winner Medical Co., Ltd. to Report Q1, 2024 Results on Apr 25, 2024

Does Winner Medical (SZSE:300888) Have A Healthy Balance Sheet?

Now 21% overvalued

There's No Escaping Winner Medical Co., Ltd.'s (SZSE:300888) Muted Earnings

Investor sentiment improves as stock rises 24%

Now 26% overvalued

Winner Medical Co., Ltd. (SZSE:300888) announces an Equity Buyback for CNY 200 million worth of its shares.

Winner Medical Co., Ltd. to Report Fiscal Year 2023 Results on Apr 25, 2024

Price target decreased by 9.2% to CN¥50.82

Third quarter 2023 earnings released: EPS: CN¥2.49 (vs CN¥0.61 in 3Q 2022)

New major risk - Revenue and earnings growth

Winner Medical Co., Ltd. to Report Q3, 2023 Results on Oct 24, 2023

Consensus EPS estimates increase by 34%, revenue downgraded

Second quarter 2023 earnings released: EPS: CN¥0.52 (vs CN¥0.92 in 2Q 2022)

Winner Medical Co., Ltd. to Report First Half, 2023 Results on Aug 16, 2023

Consensus EPS estimates increase by 38%, revenue downgraded

Winner Medical Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 02 June 2023

Winner Medical Co., Ltd. Approves Cash Dividend for the Year 2022

Price target decreased by 9.3% to CN¥84.33

First quarter 2023 earnings released: EPS: CN¥0.89 (vs CN¥0.84 in 1Q 2022)

Now 20% undervalued after recent price drop

Now 20% undervalued

Price target increased to CN¥88.97

High number of new and inexperienced directors

Now 23% undervalued after recent price drop

Third quarter 2022 earnings released: EPS: CN¥0.85 (vs CN¥0.81 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥1.28 (vs CN¥0.66 in 2Q 2021)

Price target increased to CN¥84.00

Winner Medical Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2021, Payable on May 27, 2022

Winner Medical Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2021, Payable on May 27, 2022

Winner Medical Co., Ltd. Announces Dividend for 2021

Price target decreased to CN¥84.58

Consensus revenue estimates fall by 11%

First quarter 2022 earnings: EPS and revenues miss analyst expectations

High number of new and inexperienced directors

Winner Medical Co., Ltd., Annual General Meeting, May 13, 2022

Winner Medical Co., Ltd. Announces Final Dividend Proposal for 2021

Winner Medical Co., Ltd. (SZSE:300888) agreed to acquire 55% stake in Zhejiang Longtai Medical Technology Co., Ltd. from Wu Kangping, Huang Lepei and Wu Di for CNY 727.54 million.

Price target decreased to CN¥97.71

Winner Medical Receives U.S. FDA Market Access for the Silver Alginate Dressing

Investor sentiment deteriorated over the past week

Price target decreased to CN¥110

Third quarter 2021 earnings released: EPS CN¥0.81 (vs CN¥5.63 in 3Q 2020)

Winner Medical Co., Ltd. (SZSE:300888) announces an Equity Buyback for CNY 500 million worth of its shares.

Second quarter 2021 earnings released: EPS CN¥0.66 (vs CN¥1.90 in 2Q 2020)